A Cymbalta lawsuit involves plaintiffs injured by the effects of the SSRI anti-depressant drug Cymbalta, also known as duloxetine hydrochloride. This drug is used to treat the symptoms of generalized anxiety disorder (GAD), major depression, diabetic neuropathy and fibromyalgia. Cymbalta lawsuits generally center around severe adverse reactions suffered after discontinuation of the drug.
Cymbalta is one of the first drugs approved by the FDA for the management of diabetic neuropathy – a condition causing severe pain in diabetics. Manufactured by Eli Lilly, this drug helps with neuropathy symptoms like burning, tingling and numbing sensations in the feet, legs or hands. In addition to Cymbalta’s role in the treatment of this diabetic disorder, it is also meant to help those with major depression so severe that it interferes with daily life.
A Cymbalta wrongful death lawsuit is one which stems from the use of Cymbalta followed by the subsequent suicide death of the patient. Cymbalta is undeniably tied to the increase of suicidality in patients aged 18-24 and the FDA issued a warning as far back as 2004 that “antidepressants increase the risk of suicidal thinking and behavior in children and adolescents with [major depression disorder] and other psychiatric disorders….anyone considering the use of an anti-depressant in a child or adolescent for any clinical use must balance the risk of increased suicidality with the clinical need.”
As if these risks were not enough, Cymbalta lawsuits have also centered on the increased risk of liver toxicity in patients with Chronic Liver Disease as these patients were forming hepatitis, jaundice and liver-related disorders. Although Cymbalta warning labels are not completely clear, Cymbalta is generally not recommended for use by anyone suffering from a significant liver ailment.
Many patients taking Cymbalta did not showcase adverse symptoms until attempting to discontinue use of the drug. At that point, many users across the nation reported a number of symptoms ranging from seizures and vertigo to nausea and insomnia. The warning labels, provided by manufacturer Eli Lilly, do not indicate a risk of any of these symptoms upon discontinuation of use and many Cymbalta patients have been significantly injured by the drug upon cessation.
Cymbalta lawsuits are handled within the civil realm of the justice system and plaintiffs must file a complaint for damages against the individual or corporation responsible for their injuries. In this case, drug maker Eli Lilly would be named in a Cymbalta law suit for failure to adequately warn patients of the risks of suicide, withdrawal, liver toxicity and other problems associated with this drug.
Those interested in pursuing a Cymbalta lawsuit are encouraged to contact a knowledgeable Cymbalta lawyer as soon as possible. Every state has a statute of limitations within which a claim must be filed before it is barred forever. If you believe you were injured by the drug Cymbalta, you should get started on your claim as soon as possible to avoid potential obstacles.
We are a professional law corporation based in California but nationally operational. If you are interested in a Cymbalta lawsuit, give us a call as soon as possible- we look forward to helping you with your claim.